Thursday, June 25, 2015

Cancer Research: Stress hormones could undermine breast cancer therapy ♦ new drug combo offers hope for people battling melanoma ♦ Decreased rates of high-grade cervical lesions in young women

Stress hormones could undermine breast cancer therapy Stress hormones often given to patients to treat the side effects of therapy may cause a subset of breast cancers to become treatment-resistant.
Decreased rates of high-grade cervical lesions in young women A new analysis indicates that rates of high-grade cervical lesions decreased in young US women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes in cervical cancer screening recommendations.
Study identifies multiple genetic changes linked to increased pancreatic cancer risk In a genome-wide association study believed to be the largest of its kind, researchers have uncovered four regions in the human genome where changes may increase the risk of pancreatic cancer.
Annual low-dose CT screening safe, reliable for identifying pre-cancers An annual exam using a key imaging technology could spare patients with lung nodules from unnecessary tests and surgery. The study authors found the imaging technology, called low-dose computed tomography (LDCT), to be a safe and effective screening tool to monitor those with non solid lung nodules, which in some cases are precursors to cancer.
Promising new drug combo offers hope for people battling melanoma Summer inspires many people to think about their vacation plans, however, it makes one medical oncologist think about melanoma. He hopes to be able to offer a new treatment for melanoma patients in the near future.

No comments:

Post a Comment